Manufacturing Moves: Bayer Upgrades Americas Production, GSK To Shutter Nigeria Plant
Bayer Consumer Health will supply 11 markets across the Americas after investing over $40m to upgrade its manufacturing site in Guatemala, while GSK has announced plans to shut its factory in Nigeria and rely on third-party providers.
You may also be interested in...
Notwithstanding a particularly difficult 2018, Bayer Consumer Health still has "one of the best brand portfolios," and can continue to compete with the market leaders, says CEO Werner Baumann. Consumer Health struggled particularly in the US and Europe in the 12 months, with the majority of its leading brands recording poor performances.
Bayer's Consumer Health chief Heiko Schipper is hoping a focus on innovation and a leaner portfolio will help return the business to mid-single-digit growth by 2022. The German firm has identified its North American business as the 'key area to fix'.
Enjoying a 5% sales rise, Bayer Consumer Health grew faster than the global market last year, with the company keen to repeat the performance in 2021.